Has David Seligson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $29,513 in general payments to David Seligson, MD across 602 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Seligson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Seligson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Seligson, MD

Orthopaedic Surgery · Louisville, KYNPI 1649299017

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Stryker accounts for 62.9% of it on its own, with 45 other manufacturers making up the rest. Reporting peaked in 2019 at $7,215 and has fallen 68.7% since, to $2,258 in 2025.

$29,513in general payments, 2019–2025

Across 602 payments — averaging $49.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$19K
Smith+Nephew$3K
US Implant Solutions, LLC$1K
Johnson & Johnson$1K
Medartis Inc.$809
Si-bone, Inc.$482
plus $4K from 40 others

What the payments were for

Consulting fees$12,12541%
Travel & lodging$8763%
Food & beverage$16,10155%
Education$4111%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker(2 entities)	213	$18,576
Smith+Nephew	147	$2,963
US Implant Solutions, LLC	6	$1,197
Johnson & Johnson(2 entities)	56	$1,180
Medartis Inc.	28	$809
Si-bone, Inc.	18	$482
Alpha Orthopedic Systems	12	$420
Kerecis Limited	4	$393
Acumed LLC	15	$376
Zimmer Biomet	14	$350
Illuminoss Medical, Inc.	2	$262
Blue Surgical LLC	7	$245
Misonix Inc	14	$235
Bioventus LLC	2	$154
Onkos Surgical, Inc.	1	$153
Axogen	1	$144
Integra Lifesciences Corporation	8	$137
My01 Inc.	3	$136
Skeletal Dynamics Inc	4	$122
Organogenesis Inc.	1	$109
Acera Surgical, Inc.	3	$94
Medtronic	2	$92
Acell, Inc.	3	$75
Paragon 28, Inc.	4	$71
Trimed, Inc.	2	$69
Bone Support Inc.	2	$59
Globus Medical	1	$57
AbbVie(2 entities)	3	$57
Vertex	2	$52
Neuros Medical, Inc.	2	$51
Pacira Therapeutics, Inc.	3	$47
KCI USA, Inc.	2	$42
Heron Therapeutics, Inc.	2	$41
Checkpoint Surgical, Inc	2	$33
Atricure, Inc.	1	$28
Orthofix Medical, Inc.	2	$27
Dynasplint Systems Inc.	1	$24
Anika Therapeutics, Inc.	1	$22
Polynovo North America LLC	1	$20
Acacia Pharma Inc	1	$19
BREG, Inc	1	$19
Osteocentric Technologies, Inc.	1	$16
DJO, LLC	1	$15
Heraeus Medical, LLC.	1	$15
Baudax Bio Inc.	1	$14
Next Science LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GAMMA$10,125
ADAPT$5,625
T2$3,925
Kerecis Omega3 SurgiClose$811
PROLAYER$500
ALLOWRAP$500
APTUS$411
PRO$332
INBONE$302
NA$277
Kerecis Omega3 GraftGuide$270
Kerecis Omega3 Marigen$270
Photodynamic Bone Stabilization Procedure Pack$262
HOFFMANN$250
INFINITY$197
EASYFUSE$154
AUGMENT INJECTABLE$154
ELEOS LIMB SALVAGE SYSTEM$153
VARIAX$150
AVANCE NERVE GRAFT$144

How this compares

$29,513 in reported general payments places this provider in the 80th percentile of 322 orthopaedic surgery providers in Kentucky.

See all orthopaedic surgery providers in Kentucky →

Medicare billing

Part B allowed, 2024

$93,107

Medicare patients

134

Services billed

456

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Hyclate	45	$833
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	43	$306
Meloxicam	27	$252

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Louisville

Arthur MalkaniLouisville$9.6M
Jonathan YerasimidesLouisville$4.3M
John LewisLouisville$1.5M
Akbar NawabLouisville$1M
Joseph GreeneLouisville$581K
George QuillLouisville$304K
Rodolfo Zamora RendichLouisville$292K
Richard SweetLouisville$238K
Frank BonnarensLouisville$146K
Ryan EadsLouisville$99K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →